Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 129,796,912
  • Shares Outstanding, K 5,685,366
  • Annual Sales, $ 63,627 M
  • Annual Income, $ 8,031 M
  • EBIT $ 17,236 M
  • EBITDA $ 24,249 M
  • 60-Month Beta 0.58
  • Price/Sales 2.02
  • Price/Cash Flow 5.18
  • Price/Book 1.41

Options Overview Details

View History
  • Implied Volatility 27.56% ( -0.73%)
  • Historical Volatility 38.36%
  • IV Percentile 74%
  • IV Rank 25.76%
  • IV High 52.17% on 04/10/25
  • IV Low 19.01% on 05/17/24
  • Put/Call Vol Ratio 0.81
  • Today's Volume 116,569
  • Volume Avg (30-Day) 161,315
  • Put/Call OI Ratio 0.91
  • Today's Open Interest 3,532,069
  • Open Int (30-Day) 3,404,369

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 23 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 0.57
  • Number of Estimates 5
  • High Estimate 0.60
  • Low Estimate 0.55
  • Prior Year 0.60
  • Growth Rate Est. (year over year) -5.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.87 +4.39%
on 04/21/25
24.44 -6.59%
on 04/30/25
+0.79 (+3.58%)
since 04/16/25
3-Month
20.92 +9.16%
on 04/09/25
27.24 -16.19%
on 03/10/25
-2.70 (-10.58%)
since 02/14/25
52-Week
20.92 +9.16%
on 04/09/25
31.54 -27.62%
on 07/30/24
-6.09 (-21.06%)
since 05/16/24

Most Recent Stories

More News
FDA approves Novavax COVID-19 shot but with unusual restrictions

The Food and Drug Administration has approved Novavax's COVID-19 vaccine but with unusual restrictions

NVAX : 6.73 (+7.00%)
MRNA : 24.86 (+5.12%)
PFE : 22.83 (+1.02%)
Here's How Many Shares of Pfizer You Should Own to Make $10,000 in Annual Dividend Income

PFE : 22.83 (+1.02%)
Stocks Finish Higher on Fed Rate Cut Hopes

The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.65%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.08%. June E-mini S&P...

GOOGL : 166.19 (+1.36%)
DE : 531.48 (+2.94%)
APP : 362.34 (-1.16%)
CSCO : 63.62 (-1.00%)
FI : 166.66 (+4.73%)
STE : 251.59 (+1.91%)
FL : 23.85 (-0.21%)
$IUXX : 21,427.94 (+0.43%)
AMGN : 272.41 (+0.27%)
PFE : 22.83 (+1.02%)
UNH : 291.91 (+6.40%)
ASML : 748.10 (-1.35%)
What Most-Favored-Nation Status Could Mean for Pharmaceutical Stocks

LLY : 757.39 (+3.50%)
PFE : 22.83 (+1.02%)
BMY : 46.75 (+2.05%)
3 Magnificent S&P 500 Dividend Stocks Down 62%, 63%, and 64% to Buy and Hold Forever

Temporary turbulence has resulted in opportunity for patient, bargain-hunting investors.

TGT : 98.58 (+1.56%)
PEP : 131.98 (+0.37%)
PFE : 22.83 (+1.02%)
WMT : 98.24 (+1.96%)
Stocks Settle Mixed on Chip Stock Strength and Higher Bond Yields

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up +0.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.57%. June E-mini...

TGT : 98.58 (+1.56%)
DHI : 125.75 (+1.91%)
MRK : 76.06 (+1.68%)
$IUXX : 21,427.94 (+0.43%)
PFE : 22.83 (+1.02%)
ZNM25 : 110-105s (+0.07%)
DT : 53.37 (+0.64%)
TSLA : 349.98 (+2.09%)
ESM25 : 5,975.50s (+0.71%)
PHM : 104.41 (+1.60%)
QCOM : 152.50 (-0.07%)
LOAR : 85.59 (+2.29%)
Court rules in favor of The New York Times over texts between the EU chief and a pharma boss

A top European court says the European Commission failed to provide a credible explanation for refusing The New York Times access to text messages sent between its president and a pharmaceutical boss during...

PFE : 22.83 (+1.02%)
The Zacks Analyst Blog Highlights J&J, Eli Lilly, Pfizer, Merck, Amgen

For Immediate ReleaseChicago, IL – May 13, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...

JNJ : 151.33 (+1.15%)
MRK : 76.06 (+1.68%)
LLY : 757.39 (+3.50%)
AMGN : 272.41 (+0.27%)
PFE : 22.83 (+1.02%)
Drug Stocks Recover as Trump's Order Proves Not as Bad as Feared

Shares of key drugmakers like Eli Lilly LLY, Pfizer PFE, Merck MRK, AbbVie ABBV, Gilead, Bristol-Myers, Amgen AMGN and several other U.S. pharmaceutical stocks were in the green at market close on Monday....

MRK : 76.06 (+1.68%)
LLY : 757.39 (+3.50%)
ABBV : 184.02 (+1.29%)
AMGN : 272.41 (+0.27%)
PFE : 22.83 (+1.02%)
Trump’s “Most Favored Nation” Drug Pricing Order Faces Legal and Industry Pushback

President Trump signed an executive order directing pharmaceutical companies to slash U.S. drug prices to match “most favored nation” rates abroad. The order sets 30-day price targets and threatens...

MRK : 76.06 (+1.68%)
LLY : 757.39 (+3.50%)
GILD : 102.50 (+2.15%)
PFE : 22.83 (+1.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 23.36
2nd Resistance Point 23.10
1st Resistance Point 22.97
Last Price 22.83
1st Support Level 22.57
2nd Support Level 22.31
3rd Support Level 22.18

See More

52-Week High 31.54
Fibonacci 61.8% 27.48
Fibonacci 50% 26.23
Fibonacci 38.2% 24.97
Last Price 22.83
52-Week Low 20.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar